Immtech Home page Immtech company Immtech Business Development Immtech contact Immtech Technology Immtech R&D pipeline
Immtech Investor Information Immtech Business Model Immtech investor news releases Immtech SEC Filings Immtech Corporate Governance Immtech FAQs  


Press Releases

21 May 2009
Immtech To Be Listed on OTC Market

21 April 2009
Immtech To Reorganize Research And Development Operations

03 April 2009
Immtech Announces Investment In China

02 April 2009
Immtech Receives Listing Determination Letter

27 February 2009
Immtech And Beijing Pharmaceutical Group Co. Sign Memorandum Of Understanding To Explore Developing Strategic Business Alliance

13 February 2009
Immtech To Reschedule Quarterly Conference Call

09 February 2009
Immtech Reports Fiscal Third Quarter 2009 Results

20 January 2009
Immtech Announces Appointment Of Virchow Krause As Independent Registered Public Accounting Firm

16 January 2009
Immtech Announces Sale Of Property Subsidiary In China

30 December 2008
Immtech Recieves Listing Notice From NYSE ALTERNEXT US

10 November 2008
Immtech Reports Fiscal Second Quarter 2009 Results

11 August 2008
Immtech Reports Fiscal First Quarter 2009 Results

25 June 2008
Immtech Pharmaceuticals Names Dr. Zasloff As Advisor

25 June 2008
Immtech Investor Conference Call Scheduled for June 25, 2008

18 June 2008
Immtech Pharmaceuticals And Beijing Capital Medical University Announce Joint Venture To Provide Contract Research Services In China

18 June 2008
Immtech Reports Fiscal Year End 2008 Results

03 June 2008
Immtech Announces Results From Hepatitis C Discovery Program

12 March 2008
Immtech Announces Update On Business Operations

22 February 2008
Immtech Focusing On New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine

19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008

13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor

11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results

06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008

28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1PM

26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold

05 December 2007
Immtech And BioAlliance Sign Licensing Agreement For Pafuramidine

03 December 2007
Immtech To Present At The Bank Of Montreal Healthcare Conference

29 November 2007
Dr. Jubo Liu Joins Immtech China As Development Liaison For Clinical Trials

29 November 2007
Immtech Announces Posting Of Annual Shareholders Meeting Presentation

08 November 2007
Immtech Reports Fiscal Second Quarter 2008 Results

08 November 2007
Immtech Investor Conference Call Scheduled for November 9 at 3 PM

05 November 2007
Immtech Receives $5.1 Million to further African Sleeping Sickness Clinical Trials

05 November 2007
Immtech To Present At The Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference

02 November 2007
Immtech Completes Malaria Prevention Trial

04 October 2007
Immtech Announces Interim Analysis In Phase III African Sleeping Sickness Trial

27 September 2007
Chinese SFDA Grants Immtech Fast Track Status

19 September 2007
US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness

10 September 2007
General Wesley Clark Joins Immtech As Consulting Strategic Advisor

28 August 2007
David Fleet Joins Immtech Board Of Directors

14 August 2007
Furamidine Found To Inhibit A Key Enzyme Involved In Cancer Cell DNA Repair Mechanisms

09 August 2007
Immtech Reports Fiscal First Quarter 2008 Results

08 August 2007
Immtech Retains CCG Investor Relations

20 June 2007
Immtech Completes Dosing Protocol of Malaria Prevention Trial

18 June 2007
US FDA Grants Orphan Drug Status to Immtech

13 June 2007
Immtech Reports Fiscal Year End 2007 Results

next>>

Download the free Adobe Acrobat PDF reader.

Terms of Use | Privacy Policy
© 2008 Immtech. All Rights Reserved